The Faculty of Medicine of the University of Lisbon is a public university dedicated to teaching and research activities in the field of Medicine and Health Sciences. It hosts the Instituto de Medicina Molecular (IMM).
IMM is one of the leading biomedical research institutions in Europe. The mission of IMM is to foster basic, clinical and translational biomedical research and innovation in these areas with the aim of contributing to a better understanding of disease mechanisms, developing novel predictive and diagnostics tests and developing new therapeutic approaches.
Lymphact has established a most important scientific partnership with IMM.